# OnCo record nct05630209 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05630209/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05630209", "NCT05630209" ;
  schema:name "Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)"@en ;
  schema:description "A phase 1/2 trial of Doxorubicin in brain and spinal cord tumours, run by InSightec, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05630209/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05630209> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-01-04" ;
  onco:cancers <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/dipg-dmg/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/doxorubicin/> ;
  onco:companies <https://onco.cc/companies/insightec/> .